Maval Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.20 Cr
as on 15-11-2024
- Paid Up Capital ₹ 1.20 Cr
as on 15-11-2024
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.85 Cr
as on 15-11-2024
- Revenue -16.06%
(FY 2023)
- Profit -31.84%
(FY 2023)
- Ebitda -22.12%
(FY 2023)
- Net Worth 21.88%
(FY 2023)
- Total Assets -11.31%
(FY 2023)
About Maval Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.20 Cr and a paid-up capital of Rs 1.20 Cr.
The company currently has active open charges totaling ₹4.85 Cr.
Vikas Sable, Vikas Kude, Arun Zaveri, and Nine other members serve as directors at the Company.
- CIN/LLPIN
U85100PN2015PTC153855
- Company No.
153855
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jan 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Maval Healthcare?
Board Members(12)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikas Sable  | Director | 29-Jan-2015 | Current |
| Vikas Kude | Director | 29-Jan-2015 | Current |
| Arun Zaveri | Director | 29-Jan-2015 | Current |
| Santosh Sabnis | Director | 29-Jan-2015 | Current |
| Siddharth Killawala | Director | 28-Jun-2023 | Current |
| Kiran Killavala | Director | 28-Jun-2023 | Current |
Financial Performance of Maval Healthcare.
Maval Healthcare Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.06% decrease. The company also saw a substantial fall in profitability, with a 31.84% decrease in profit. The company's net worth Soared by an impressive increase of 21.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maval Healthcare?
In 2023, Maval Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Omkar Accident Hospital And Research Center Private LimitedActive 11 years 11 months
Vikas Sable is a mutual person
- Fortune's Sparsh Healthcare Private LimitedActive 9 years 9 months
Vikas Kude and Rahul Bade are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Syndicate Bank Creation Date: 29 May 2015 | ₹4.85 Cr | Open |
How Many Employees Work at Maval Healthcare?
Unlock and access historical data on people associated with Maval Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maval Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maval Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
